Immediate Impact
23 standout
Citing Papers
Applications of SGLT2 inhibitors beyond glycaemic control
2024 Standout
Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
2023 Standout
Works of David Dorey being referenced
Randomized trial showing efficacy and safety of twice‐daily remogliflozin etabonate for the treatment of type 2 diabetes
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David Dorey | 109 | 73 | 23 | 41 | 10 | 150 | |
| Yann Quertainmont | 83 | 34 | 17 | 110 | 14 | 193 | |
| Gulam Latiff | 148 | 134 | 11 | 34 | 8 | 212 | |
| Ilaria Caramma | 103 | 87 | 19 | 124 | 14 | 235 | |
| Livia Giner | 79 | 67 | 17 | 74 | 12 | 182 | |
| Katherine E. Clarridge | 94 | 103 | 10 | 28 | 9 | 183 | |
| Claudia Fabrizio | 132 | 48 | 29 | 102 | 17 | 216 | |
| Myriam Kirstetter | 136 | 133 | 19 | 43 | 14 | 203 | |
| Veronique Obry‐Roguet | 117 | 66 | 7 | 71 | 12 | 207 | |
| Joseph Lutaakome | 125 | 48 | 8 | 57 | 10 | 197 | |
| Sophie Farbos | 182 | 152 | 12 | 34 | 12 | 252 |
All Works
Loading papers...